Occurrence of Anoplocephala perfoliata infection in horses in Ontario, Canada and associations with colic and management practices.
Infection with the tapeworm Anoplocephala perfoliata has been found to be associated with equine colic in horses in the United Kingdom. Using a matched case-control study design, data collected from 117 pairs of horses in Ontario were examined for evidence of associations between risk of colic and A. perfoliata infection, and between seropositivity to infection and management practices. Cases were horses in southern Ontario diagnosed with colic by local veterinarians, and control horses were from the same stables as cases and were matched by age, breed and gender where possible. Infection status was defined on the basis of positive results upon coprological examination, and/or seropositivity to a 12/13 kDa A. perfoliata secretory protein. Fifty-six percent of the 234 horses were seropositive for A. perfoliata, but eggs were found in samples from only 6% of horses. Horses dependent on pasture for a large part of their diet were significantly more likely to have ELISA optical density levels above 0.600 compared to other horses (odds ratio [OR]=6.38; p=0.029). This finding identified exposure to pasture as an important source of A. perfoliata infection in the horses used in the study. In a subset of 46 pairs of horses for which control horses had no known history of colic, a statistically significant negative association was found between the risk of colic and optical density (OD) levels >0.200-0.600, relative to OD levels < or = 0.090 (OR=0.08; p=0.017). There was no other statistical evidence of an association between the risk of colic and A. perfoliata infection.
Trotz-Williams
Lise
L
Department of Pathobiology, Ontario Veterinary College, University of Guelph, Ontario N1G 2W1, Canada. ltrotzwi@uoguelpha.ca
Physick-Sheard
Peter
P
McFarlane
Heather
H
Pearl
David L
DL
Martin
S Wayne
SW
Peregrine
Andrew S
AS
D017677:Age Distribution; D000822:Animal Husbandry / Q000379:methods*; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D016022:Case-Control Studies; D002589:Cestoda / Q000302:isolation & purification*; D002590:Cestode Infections / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000662:veterinary*; D003085:Colic / Q000150:complications / Q000469:parasitology / Q000662:veterinary*; D005260:Female; D005767:Gastrointestinal Diseases / Q000150:complications / Q000469:parasitology / Q000662:veterinary; D006734:Horse Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000469:parasitology*; D006736:Horses; D008297:Male; D009864:Ontario; D015995:Prevalence; D012307:Risk Factors
D000871:Anthelmintics